660 related articles for article (PubMed ID: 28109572)
21. N2 disease in T1 non-small cell lung cancer.
Defranchi SA; Cassivi SD; Nichols FC; Allen MS; Shen KR; Deschamps C; Wigle DA
Ann Thorac Surg; 2009 Sep; 88(3):924-8. PubMed ID: 19699921
[TBL] [Abstract][Full Text] [Related]
22. [The rule of lymph node metastasis of adenosquamous carcinoma of the lung].
Li J; Zhang DC; He J; Liu XY; Mu JW; Zhang LZ
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):524-7. PubMed ID: 19950701
[TBL] [Abstract][Full Text] [Related]
23. Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?
Deng HY; Zhou J; Wang RL; Jiang R; Zhu DX; Tang XJ; Zhou Q
Ann Surg Oncol; 2020 Feb; 27(2):472-480. PubMed ID: 31617120
[TBL] [Abstract][Full Text] [Related]
24. Long-term survival after complete mediastinal lymph node resection and lobectomy in patients with bulky N2 non-small cell lung cancer.
Sakuraba M; Takahashi N; Oh S; Miyasaka Y; Inagaki T; Suzuki K
Ann Thorac Cardiovasc Surg; 2011; 17(2):124-9. PubMed ID: 21597408
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of extended mediastinal lymph node dissection on the basis of clinicopathological analysis of nodal involvement in bronchogenic carcinoma].
Watanabe Y; Hayashi Y; Takabatake I; Shimizu J; Murakami S; Morita K; Arano Y; Nonomura A
Kyobu Geka; 1994 Jan; 47(1):4-9. PubMed ID: 8277631
[TBL] [Abstract][Full Text] [Related]
26. Pre- and intra-operative mediastinal staging in non-small-cell lung cancer.
Lardinois D
Swiss Med Wkly; 2011; 141():w13168. PubMed ID: 21384283
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
28. Superior and basal segment lung cancers in the lower lobe have different lymph node metastatic pathways and prognosis.
Watanabe S; Suzuki K; Asamura H
Ann Thorac Surg; 2008 Mar; 85(3):1026-31. PubMed ID: 18291191
[TBL] [Abstract][Full Text] [Related]
29. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
30. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
31. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
[TBL] [Abstract][Full Text] [Related]
32. Prognosis of completely resected pN2 non-small cell lung carcinomas: What is the significant node that affects survival?
Okada M; Tsubota N; Yoshimura M; Miyamoto Y; Matsuoka H
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):270-5. PubMed ID: 10425000
[TBL] [Abstract][Full Text] [Related]
33. [The relationship between the pathways of the lymphatic drainage into the mediastinal nodes and the survival rate for N2 lung cancers underwent curative resection].
Ohta S; Inaba H; Nishimura T; Takamochi K; Ishida I
Kyobu Geka; 1998 Mar; 51(5):357-62; discussion 362-4. PubMed ID: 9594492
[TBL] [Abstract][Full Text] [Related]
34. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
Bille A; Woo KM; Ahmad U; Rizk NP; Jones DR
Eur J Cardiothorac Surg; 2017 Apr; 51(4):674-679. PubMed ID: 28200091
[TBL] [Abstract][Full Text] [Related]
35. Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis.
Hishida T; Miyaoka E; Yokoi K; Tsuboi M; Asamura H; Kiura K; Takahashi K; Dosaka-Akita H; Kobayashi H; Date H; Tada H; Okumura M; Yoshino I;
J Thorac Oncol; 2016 Sep; 11(9):1529-37. PubMed ID: 27249959
[TBL] [Abstract][Full Text] [Related]
36. Distribution and prognosis of mediastinal lymph node metastases of nonsmall cell lung cancer.
Guo D; Ni Y; Lv X; Zhang Z; Ye P
J Cancer Res Ther; 2016 Oct; 12(Supplement):120-125. PubMed ID: 27721268
[TBL] [Abstract][Full Text] [Related]
37. Transbronchial needle aspiration cytology of subcarinal lymph nodes for the staging procedure in the diagnosis of lung cancer.
Aono H; Okamoto H; Kunikane H; Nagatomo A; Watanabe K; Nagai A
Respirology; 2006 Nov; 11(6):782-5. PubMed ID: 17052308
[TBL] [Abstract][Full Text] [Related]
38. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.
Cerfolio RJ; Bryant AS; Eloubeidi MA
Chest; 2006 Dec; 130(6):1791-5. PubMed ID: 17166998
[TBL] [Abstract][Full Text] [Related]
39. Is lobe specific lymph node dissection adequate for cN0-1 non-small cell lung cancer?
Fang L; Xu J; Ye B; Yu G; Chen G; Yang J
J Cardiothorac Surg; 2020 Feb; 15(1):46. PubMed ID: 32106870
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Accuracy of Mediastinal Lymph Node Staging Techniques in the Preoperative Assessment of Nonsmall Cell Lung Cancer Patients.
Fréchet B; Kazakov J; Thiffault V; Ferraro P; Liberman M
J Bronchology Interv Pulmonol; 2018 Jan; 25(1):17-24. PubMed ID: 29261576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
